Pharma co-director denies stocking Remdesivir vials in Mumbai

Remdesivir is listed for use in serious COVID-19 patients.
The Bruck Pharma director, who was questioned by Mumbai police over the company's Remdesivir stock, has denied stocking the vials in the city and claimed the consignment has been moved to a godown in Daman, a police official said on Tuesday.
Remdesivir is listed for use in serious COVID-19 patients. In view of a sudden spike in demand of the drug due to the surge in COVID-19 cases, the Centre last week banned its export till the situation improves.
The Mumbai police on Saturday questioned Rajesh Dokania, the director of the Daman-based pharmaceutical company that manufactures Remdesivir vials, following information that around 60,000 vials were going to be flown abroad by air cargo, despite a ban on the export of the drug.

Related Keywords

Mumbai ,Maharashtra ,India ,Surat ,Gujarat ,Rajesh Dokania ,Pravin Darekar ,Bruck Pharma ,Union Territory Of Daman ,Drug Administration ,Union Territory ,Drugs Controller General ,Remdesivir ,Drug ,Remdesivir Vials ,Export Of Remdesivir ,Devendra Fadnavis ,மும்பை ,மகாராஷ்டிரா ,இந்தியா ,சூரத் ,குஜராத் ,பிராவின் ட்ரெகர் ,தொழிற்சங்கம் பிரதேசம் ஆஃப் தமன் ,தொழிற்சங்கம் பிரதேசம் ,மருந்துகள் கட்டுப்படுத்தி ஜநரல் ,மருந்து ,